Jiangsu Recbio Technology Co., Ltd. (HKG:2179)
Hong Kong · Delayed Price · Currency is HKD 4.370
-0.570 (-11.54%)
Feb 13, 2026, 4:08 PM HKT
Jiangsu Recbio Technology Market Cap
Jiangsu Recbio Technology has a market cap or net worth of 3.05 billion as of February 13, 2026. Its market cap has decreased by -23.47% in one year.
Market Cap
3.05B
Enterprise Value
3.85B
Revenue
31.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.37
Market Cap Chart
Since March 31, 2022, Jiangsu Recbio Technology's market cap has decreased from 12.10B to 3.05B, a decrease of -74.81%. That is a compound annual growth rate of -29.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 2.70B | 9.25% |
| Dec 31, 2025 | 2.47B | -45.80% |
| Dec 31, 2024 | 4.55B | -12.74% |
| Dec 29, 2023 | 5.22B | -56.10% |
| Dec 30, 2022 | 11.88B | -1.79% |
| Mar 31, 2022 | 12.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Luzhu Biotechnology | 4.56B |
| Qyuns Therapeutics | 4.45B |
| AIM Vaccine | 3.77B |
| Medtide | 3.43B |
| BioDlink International Company | 3.25B |
| Clover Biopharmaceuticals | 2.89B |
| SinoMab BioScience | 2.48B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 2.35B |